David McWilliams
CIK 1303311 · CEO · last filed 2024-12-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.92M
Companies
3
Total Filings
11
Lifetime Open-Market Net
$28.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GLSI | Director | 620,301 | $24.06 | $14.92M | $28.6K | 6 | 2024-12-27 |
| Acer Therapeutics Inc. (OPXAW) Delisted | CEO | — | — | — | $0 | 4 | 2009-08-27 |
| Acer Therapeutics Inc. (OPXA) Delisted | Chief Executive Officer | — | — | — | $0 | 1 | 2007-06-19 |
Recent Filings · Page 2 of 2
11 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-06-19 | Acer Therapeutics Inc. (OPXA) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–11 of 11
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.